Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD, MS
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- British Columbia Children'S Hosp-Vancouver
Vancouver, British Columbia, Canada
- Hopital Sainte-Justine
Montreal, Quebec, Canada
- Mcgill University - Montreal
Montreal, Quebec, Canada
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Ann and Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Johns Hopkins
Baltimore, Maryland, United States
- Dana Farber Cancer Institute/children'S Hospital of Boston
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Washington University/st. Louis Children'S Hospital
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Medical Center of Dallas
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Midwest Children'S Cancer
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2013
- Primary completion
- 23 Sept 2016
- Completion
- 31 Dec 2016
- Last update posted
- 8 Dec 2022
- Registered enrollment
- 47
- Registry id
- NCT01998633
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.